Willison, A.G.; Hagler, R.; Weise, M.; Elben, S.; Huntemann, N.; Masanneck, L.; Pfeuffer, S.; Lichtenberg, S.; Golombeck, K.S.; Preuth, L.-M.;
et al. Effects of Anti-CD20 Antibody Therapy on Immune Cell Dynamics in Relapsing-Remitting Multiple Sclerosis. Cells 2025, 14, 552.
https://doi.org/10.3390/cells14070552
AMA Style
Willison AG, Hagler R, Weise M, Elben S, Huntemann N, Masanneck L, Pfeuffer S, Lichtenberg S, Golombeck KS, Preuth L-M,
et al. Effects of Anti-CD20 Antibody Therapy on Immune Cell Dynamics in Relapsing-Remitting Multiple Sclerosis. Cells. 2025; 14(7):552.
https://doi.org/10.3390/cells14070552
Chicago/Turabian Style
Willison, Alice G., Ramona Hagler, Margit Weise, Saskia Elben, Niklas Huntemann, Lars Masanneck, Steffen Pfeuffer, Stefanie Lichtenberg, Kristin S. Golombeck, Lara-Maria Preuth,
and et al. 2025. "Effects of Anti-CD20 Antibody Therapy on Immune Cell Dynamics in Relapsing-Remitting Multiple Sclerosis" Cells 14, no. 7: 552.
https://doi.org/10.3390/cells14070552
APA Style
Willison, A. G., Hagler, R., Weise, M., Elben, S., Huntemann, N., Masanneck, L., Pfeuffer, S., Lichtenberg, S., Golombeck, K. S., Preuth, L.-M., Rolfes, L., Öztürk, M., Ruck, T., Melzer, N., Korsen, M., Hauser, S. L., Hartung, H.-P., Lang, P. A., Pawlitzki, M.,
... Meuth, S. G.
(2025). Effects of Anti-CD20 Antibody Therapy on Immune Cell Dynamics in Relapsing-Remitting Multiple Sclerosis. Cells, 14(7), 552.
https://doi.org/10.3390/cells14070552
